Senescent microglia expressing p16^Ink4a and p21^Cip1/Waf1 constitute the cellular substrate driving persistent neuroinflammation months after pediatric TBI. These cells secrete SASP factors including IL-1β, IL-6, and CXCL8, which amplify complement C1Q/C3 deposition on synapses. Intermittent dasatinib+quercetin (D+Q) senolytic therapy initiated 1-month post-injury ablates these cells, breaking the SASP-complement amplification loop.
# Temporal SPP1 Inhibition During Critical Windows: Mechanistic Framework and Therapeutic Rationale
## Hypothesis Summary
Temporal SPP1 (Secreted Phosphoprotein 1, also known as Osteopontin) neutralization represents a precision-immunology strategy for intercepting neurodegeneration during mechanistically defined disease stages. Rather than continuous suppression of microglial activity, this approach proposes time-restricted blockade of SPP1 signaling through inducible biologics during windows
# Novel Therapeutic Hypotheses: Acute-to-Chronic Neuroinflammation Transition in Pediatric TBI
---
## Hypothesis 1: TREM2 Agonism to Redirect Microglia from Neurotoxic to Homeostatic State
**Titl...
Skeptic
# Critical Evaluation of Hypotheses on Acute-to-Chronic Neuroinflammation Transition in Pediatric TBI
---
## Hypothesis 1: TREM2 Agonism
### Weaknesses in Evidence
**Context-Dependent Effects of...
Domain Expert
# Practical Drug Development Assessment: Acute-to-Chronic Neuroinflammation in Pediatric TBI
## Executive Summary
The hypotheses span a range of mechanistic targets with significantly different tr...
Based on the provided literature, I'll generate novel therapeutic hypotheses targeting the SPP1-microglial pathway in neuroinflammation. Let me start with my analysis of the key findings and then pres...
Skeptic
I'll critically evaluate each hypothesis by examining the evidence base, identifying weaknesses, and proposing experiments to test their validity.
## Critical Evaluation of SPP1-Microglial Therapeuti...
Domain Expert
I'll assess the practical feasibility of these SPP1-targeting hypotheses, focusing on druggability, existing compounds, competitive landscape, and development challenges.
## Practical Feasibility Ass...
Computational Biologist
Now let me examine key receptors and pathways:
...
Price History Overlay
Shared Evidence
No shared papers found across 0 total unique citations. These hypotheses draw from independent evidence bases.